Shehab Mohamed: A Systematic Review on Bleeding as Initial Presentation of CML
Shehab Mohamed, Hematologist at Hamad Medical Corporation, shared on LinkedIn about a recent article by Mohammad ALTermanini et al, published in Clinical and Applied Thrombosis/Hemostasis, adding:
”Continuing our work in myeloid neoplasms and hemostasis
We are proud to share our latest progress in this evolving field.
After previously exploring:
- Bleeding in acute myeloid leukemia (AML)
- Thrombosis in acute promyelocytic leukemia (APL)
- We now expand our work with a new systematic review on bleeding as the initial presentation of chronic myeloid leukemia (CML).
Key findings from our review:
- 53 reported cases identified across the literature
- Strong male predominance (74%)
- Median age: 45 years
Central nervous system bleeding was the most common presentation (40%), followed by:
- Soft tissue hematomas (25%)
- Visceral/splenic bleeding (19%)
- Most patients presented with marked hyperleukocytosis
Despite severity:
- 62% survived
- 21% mortality, mainly due to intracranial hemorrhage or splenic rupture
Key message: Bleeding can be the first manifestation of CML – and should not be overlooked, especially in patients presenting with unexplained hemorrhage and extreme leukocytosis.
This work highlights:
- The complex interplay between malignancy and hemostasis
- The need for early recognition
- The importance of multidisciplinary management
We are excited to keep pushing forward in this field with our team – more to come.”
Title: Review of Bleeding as Initial Presentation in Patients with Chronic Myeloid Leukemia
Authors: Mohammad ALTermanini, Omar Altrmanini, Abdulrhaman F. Al-Mashdali, Ashraf Ahmed, Sara Saeed, Mohamed Fawzi Mudarres, Mohamed Saeed, ElMustafa Abdalla, Dina Soliman, Kalpana Singh, Amin Saied, Motaz Almahmood, Aasir Suliman, Hanaa Qasim, Tareq Abuasab, Fadi Haddad, Mohamed Yassin, Shehab Fareed

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 28, 2026, 13:26Gleb Tsipursky: How a Personal AI Health Agent Helped Avert Disaster
-
Apr 28, 2026, 13:23Piotr Czempik: Anti-Xa-Guided Enoxaparin Prophylaxis in Extreme Obesity
-
Apr 28, 2026, 13:03Ronald Tully: Uncovering the Hidden Risks Behind Nicotiana Tabacum
-
Apr 28, 2026, 11:26Muhammad Aqib Faizan: New Evidence Supports Optimized Riociguat Use in Pulmonary Hypertension
-
Apr 28, 2026, 11:19Roshni Kulkarni: A Legacy in Blood Disorders Care That Must Be Rebuilt
-
Apr 28, 2026, 11:12Asare Obed: Artificial Blood That Could Eliminate the Need for Blood Type Matching
-
Apr 28, 2026, 10:59Alan Dursun: Global Training in Kuala Lumpur Advancing Advocacy and Patient Impact
-
Apr 28, 2026, 10:50Louise St. Germain Bannon: Last Day for Early Registration for ISTH 2026 in Paris
-
Apr 28, 2026, 06:57Valeria Caso: Why Now Is the Time to Act on Global Health Prevention